Connor, Clark & Lunn Investment Management Ltd. - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 67 filers reported holding PDS BIOTECHNOLOGY CORP in Q4 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q2 2023$139,869
-52.1%
27,807
-41.5%
0.00%
-50.0%
Q1 2023$292,260
-20.1%
47,522
+71.4%
0.00%0.0%
Q4 2022$365,99627,7270.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q4 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 117,242$311,0000.07%
Andesa Financial Management Inc. 16,655$44,0000.04%
Sofinnova Investments, Inc. 142,635$378,0000.03%
INSPIRION WEALTH ADVISORS, LLC 22,875$61,0000.02%
REGENTATLANTIC CAPITAL LLC 15,753$42,0000.00%
Ellis Investment Partners, LLC 2,250$5,0000.00%
tru Independence LLC 500$00.00%
Renaissance Technologies 120,269$319,0000.00%
D. E. Shaw & Co., Inc. 13,281$35,0000.00%
VANGUARD GROUP INC 36,206$96,0000.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders